Isosorbide dinitrate and Acetylcysteine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Isosorbide dinitrate (isosorbide dinitrate) and Acetylcysteine (acetylcysteine). Common drug interactions include emphysema among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Isosorbide dinitrate and Acetylcysteine. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Isosorbide dinitrate?

Isosorbide dinitrate has active ingredients of isosorbide dinitrate. It is often used in angina. eHealthMe is studying from 13,180 Isosorbide dinitrate users. Check the latest studies of Isosorbide dinitrate.

What is Acetylcysteine?

Acetylcysteine has active ingredients of acetylcysteine. It is often used in cough. eHealthMe is studying from 11,563 Acetylcysteine users. Check the latest studies of Acetylcysteine.



On Jul, 11, 2026

62 people who take Isosorbide dinitrate and Acetylcysteine together, and have interactions are studied.

Isosorbide dinitrate and Acetylcysteine drug interactions.

What are the common drug interactions of Isosorbide Dinitrate and Acetylcysteine, by gender? *:

female:

  1. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  2. Pulmonary oedema (fluid accumulation in the lungs)
  3. Haemoglobin decreased
  4. Blood urea increased
  5. Abnormal faeces (abnormal stool)
  6. Acute respiratory failure
  7. Aortic arteriosclerosis (hardening of the aortic arteries)
  8. Aortic disorder
  9. Arthralgia (joint pain)
  10. Basophil count increased

male:

  1. Pyrexia (fever)
  2. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  3. Anxiety
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  5. Cardiomegaly (increased size of heart than normal)
  6. Chronic obstructive airways disease
  7. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  8. Epidermal necrolysis (skin condition that is usually caused by a reaction to drugs)
  9. Fatigue (feeling of tiredness)
  10. Fear

What are the common drug interactions of Isosorbide Dinitrate and Acetylcysteine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Cardiomegaly (increased size of heart than normal)
  2. Cataract (clouding of the lens inside the eye)
  3. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  4. Gamma-glutamyltransferase increased
  5. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)
  6. Mitral valve incompetence (inefficient heart valve)
  7. Pleural effusion (water on the lungs)
  8. Pneumonia
  9. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  10. Pulmonary hypertension (increase in blood pressure in the lung artery)

60+:

  1. Pneumonia
  2. Urinary tract infection
  3. Pulmonary oedema (fluid accumulation in the lungs)
  4. Haemoglobin decreased
  5. Blood urea increased
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Abnormal faeces (abnormal stool)
  8. Arthralgia (joint pain)
  9. Oedema peripheral (superficial swelling)
  10. Spinal osteoarthritis (joint cartilage loss in spine)

What are the existing conditions these people have? *

  1. High Blood Pressure: 18 people, 29.03%
  2. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 14 people, 22.58%
  3. Pain: 12 people, 19.35%
  4. Hypokalemia (low potassium): 11 people, 17.74%
  5. Anaesthesia: 10 people, 16.13%
  6. Sedation: 9 people, 14.52%
  7. Oedema (fluid collection in tissue): 9 people, 14.52%
  8. Blood Potassium Decreased: 9 people, 14.52%
  9. Cardiac Failure: 9 people, 14.52%
  10. Urination - Excessive Volume: 8 people, 12.90%

* Approximation only. Some reports may have incomplete information.

Do you take Isosorbide dinitrate and Acetylcysteine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Isosorbide dinitrate and Acetylcysteine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Isosorbide dinitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Acetylcysteine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isosorbide dinitrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acetylcysteine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide dinitrate and acetylcysteine (the active ingredients of Isosorbide dinitrate and Acetylcysteine, respectively), and Isosorbide dinitrate and Acetylcysteine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: